Marketing Code of Practice

Table of Contents

The regulatory landscape for complementary medicines in Australia was overseen by the Therapeutic Goods Administration (TGA), a division of the Australian Government Department of Health. The TGA ensures the safety, quality, and efficacy of therapeutic goods, including complementary medicines.

The “Code of Practice for Complementary Medicines” in Australia outlines the guidelines and standards to which manufacturers and sponsors of these products should adhere. Please note that regulations and procedures may change, so checking for the most recent information on the TGA website or other official sources is essential. Here are some key aspects typically covered in the Code of Practice:

Quality Standards

Complementary medicines must meet specified quality standards. This includes using Good Manufacturing Practice (GMP) principles, which ensure that the manufacturing processes are consistent and produce high-quality products.

Evidence of Efficacy

Sponsors must provide evidence supporting therapeutic claims about their products. This evidence may include clinical trial data or references to scientific literature.

Ingredients and Formulation

The Code of Practice typically addresses the acceptable ingredients in complementary medicines and the proper formulation of these products. This helps ensure that the ingredients are safe and used at appropriate concentrations.

Labelling and Packaging

Regulations often cover requirements for labelling and packaging, including accurate representation of ingredients, dosage instructions, and any therapeutic claims. Precise and accurate labelling is crucial for consumers to make informed choices.

Advertising and Promotion

The code may include guidelines on advertising and promoting complementary medicines. This helps prevent misleading or false claims and ensures that marketing materials are accurate and evidence-based.

Post-Market Monitoring

The TGA may conduct post-market monitoring to assess the ongoing safety and efficacy of complementary medicines. This includes monitoring adverse events and taking appropriate regulatory action if safety concerns arise.

Please consult the latest documents and guidelines from the TGA and our website for the most up-to-date information, and stakeholders must stay informed about any amendments or updates to the Code of Practice to ensure compliance with current regulations.